- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Idera Pharmaceuticals Inc
+ Add to WatchlistIDRA:US
0.6900 USD 0.0100 1.47%As of 20:10:00 ET on 05/21/2013.
Snapshot for Idera Pharmaceuticals Inc (IDRA)
| Open: | 0.6700 | Day's Range: | 0.6600 - 0.7600 | Volume: | 82,809 |
|---|---|---|---|---|---|
| Previous Close: | 0.6800 | 52wk Range: | 0.1866 - 1.2200 | 1-Yr Rtn: | -31.00% |
Key Statistics for IDRA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.7100 |
| Est. EPS (USD) (12/2013) | -0.4200 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 31.16 |
| Shares Outstanding (M) | 45.16 |
| 30 Day Average Volume | 280,241 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 389.2146 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for IDRA
Company Profile & Key Executives for IDRA
Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.
| Sudhir AgrawalChairman/President/CEO | Louis J Arcudi IIISenior VP/CFO/Treasurer/Secy |
| Robert D ArbeitVP:Clinical Development | Timothy M SullivanVP:Dev Programs & Alliance |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
IDRA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page